tetano
Editor, Senior Moderator
Front Immunol
. 2021 Nov 10;12:674074.
doi: 10.3389/fimmu.2021.674074. eCollection 2021.
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
Hao Zhang[SUP] 1 [/SUP], Bo Shao[SUP] 1 [/SUP], Qin Dang[SUP] 1 [/SUP], Zhuang Chen[SUP] 1 [/SUP], Quanbo Zhou[SUP] 1 [/SUP], Hong Luo[SUP] 2 [/SUP], Weitang Yuan[SUP] 1 [/SUP], Zhenqiang Sun[SUP] 1 3 [/SUP]
Affiliations
Abstract
As a new infectious disease, COVID-19 is spread through the respiratory tract in most cases. Its source and pathological mechanism are not clear. The most common clinical feature is pulmonary infection. Also, a lot patients have gastrointestinal symptoms. Angiotensin-converting enzyme 2 (ACE2) is a functional cellular receptor for SARS-CoV-2, which is like SARS-CoV, a coronavirus associated with severe acute respiratory syndrome (SARS) outbreak in 2003. The tissues and cells expressing ACE2 are potential targets for SARS-CoV-2 infection, and the high expression of ACE2 in intestinal epithelial cells marks that SARS-CoV-2 may directly infect intestinal epithelial cells. Recent studies also suggest that SARS-CoV-2 existed and replicated in intestinal environment for a long time. The interaction between SARS-CoV-2 and RAS system leads to the decrease of local anti-inflammatory ability. The virus cycle leads to excessive imbalance of immune response and cytokine release. The downregulation of ACE2 after viral infection leads to gastrointestinal dysfunction. The above are the causes of gastrointestinal symptoms. Here, we reviewed the possible causes and mechanisms of gastrointestinal symptoms caused by COVID-19. Additionally, we discussed the influence of gastrointestinal symptoms on the prognosis of patients.
Keywords: RAS system; angiotensin-converting enzyme 2 (ACE2); coronavirus disease 2019 (COVID-19); cytokine storm; gastrointestinal tract; gut–lung axis.
. 2021 Nov 10;12:674074.
doi: 10.3389/fimmu.2021.674074. eCollection 2021.
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
Hao Zhang[SUP] 1 [/SUP], Bo Shao[SUP] 1 [/SUP], Qin Dang[SUP] 1 [/SUP], Zhuang Chen[SUP] 1 [/SUP], Quanbo Zhou[SUP] 1 [/SUP], Hong Luo[SUP] 2 [/SUP], Weitang Yuan[SUP] 1 [/SUP], Zhenqiang Sun[SUP] 1 3 [/SUP]
Affiliations
- PMID: 34858386
- PMCID: PMC8631495
- DOI: 10.3389/fimmu.2021.674074
Abstract
As a new infectious disease, COVID-19 is spread through the respiratory tract in most cases. Its source and pathological mechanism are not clear. The most common clinical feature is pulmonary infection. Also, a lot patients have gastrointestinal symptoms. Angiotensin-converting enzyme 2 (ACE2) is a functional cellular receptor for SARS-CoV-2, which is like SARS-CoV, a coronavirus associated with severe acute respiratory syndrome (SARS) outbreak in 2003. The tissues and cells expressing ACE2 are potential targets for SARS-CoV-2 infection, and the high expression of ACE2 in intestinal epithelial cells marks that SARS-CoV-2 may directly infect intestinal epithelial cells. Recent studies also suggest that SARS-CoV-2 existed and replicated in intestinal environment for a long time. The interaction between SARS-CoV-2 and RAS system leads to the decrease of local anti-inflammatory ability. The virus cycle leads to excessive imbalance of immune response and cytokine release. The downregulation of ACE2 after viral infection leads to gastrointestinal dysfunction. The above are the causes of gastrointestinal symptoms. Here, we reviewed the possible causes and mechanisms of gastrointestinal symptoms caused by COVID-19. Additionally, we discussed the influence of gastrointestinal symptoms on the prognosis of patients.
Keywords: RAS system; angiotensin-converting enzyme 2 (ACE2); coronavirus disease 2019 (COVID-19); cytokine storm; gastrointestinal tract; gut–lung axis.